CC
STIM icon

Cannell Capital’s Neuronetics STIM Stock Holding History

Cannell Capital’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,314,266
Closed -$999K – 57
2024
Q3 		$999K Sell
1,314,266
-1,067,037
-45% -$1.4M 0.21% 39
2024
Q2 		$4.29M Sell
2,381,303
-81,953
-3% -$236K 0.97% 28
2024
Q1 		$11.7M Sell
2,463,256
-306,012
-11% -$1.08M 2.52% 21
2023
Q4 		$8.03M Sell
2,769,268
-64,714
-2% -$102K 1.74% 22
2023
Q3 		$3.83M Buy
2,833,982
+65,240
+2% +$114K 0.89% 29
2023
Q2 		$5.95M Sell
2,768,742
-359,077
-11% -$871K 1.19% 32
2023
Q1 		$9.1M Sell
3,127,819
-118,312
-4% -$597K 1.76% 22
2022
Q4 		$22.3M Sell
3,246,131
-217,715
-6% -$1.03M 4.49% 6
2022
Q3 		$11M Hold
3,463,846
– – 2.52% 16
2022
Q2 		$11.1M Buy
3,463,846
+713,493
+26% +$2.07M 2.23% 18
2022
Q1 		$8.33M Buy
2,750,353
+118,131
+4% +$399K 1.26% 29
2021
Q4 		$11.7M Buy
2,632,222
+547,219
+26% +$2.68M 1.86% 22
2021
Q3 		$13.7M Buy
2,085,003
+772,665
+59% +$7.41M 2.25% 21
2021
Q2 		$21M Buy
1,312,338
+1,248,029
+1,941% +$17.2M 3.37% 13
2021
Q1 		$796K Buy
+64,309
New +$986K 0.18% 42
2020
Q4 		– Sell
-226,423
Closed -$1.1M – 66
2020
Q3 		$1.1M Buy
+226,423
New +$859K 0.4% 38

Other funds holding STIM

MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Cannell Capital's STIM Position: Q4 2024 in Review

Cannell Capital sold out of Neuronetics (STIM) in Q4 2024, closing a stake of 1,314,266 shares — an estimated $999K sold.

Cannell Capital first reported a position in STIM in Q3 2020 and held it in 16 quarters. The position peaked at $22.3M in Q4 2022. 45 funds tracked by Wall St. Rank hold STIM as of Q4 2024.

  • Cannell Capital reported no remaining Neuronetics position as of Q4 2024 after selling out during the quarter.
  • Cannell Capital sold 1,314,266 Neuronetics shares in Q4 2024, an estimated $999K.
  • Cannell Capital first reported a position in Neuronetics in Q3 2020 and held it in 16 quarters.
  • Cannell Capital's Neuronetics position peaked at $22.3M in Q4 2022.
  • 45 funds tracked by Wall St. Rank held Neuronetics as of Q4 2024.

Based on Cannell Capital's 13F filing for Q4 2024, filed 13 Feb 2025.